Summary: Cancer genotype–specific synthetic lethal vulnerabilities represent promising therapeutic targets. In this issue of Cancer Discovery, Ogiwara and colleagues uncover a synthetic lethal relationship between two histone acetyl transferase paralogs, CBP and p300, highlighting that cancer cells deficient in CBP are uniquely sensitized to genetic and chemical inhibition of p300. Cancer Discov; 6(4); 350–2. ©2016 AACR.
See related article by Ogiwara et al., p. 430.
- ©2016 American Association for Cancer Research.